期刊文献+

左向右分流型先天性心脏病病儿血浆BNP和CT-1变化 被引量:3

CHANGES OF PLASMA LEVELS OF BRAIN NATRIURETIC PEPTIDE AND CARDIOTROPHIN-1 IN CHILDREN WITH LEFT-TO-RIGHT SHUNT CONGENITAL HEART DISEASE
下载PDF
导出
摘要 目的探讨左向右分流先天性心脏病(CHD)病儿血浆脑钠肽(BNP)、心脏营养素-1(CT-1)水平的变化及临床意义。方法应用ELISA法测定25例左向右分流CHD病儿和10例正常儿童血浆BNP和CT-1水平,观察血浆BNP和CT-1水平与肺动脉压力、左心室射血分数(EF)、左心室短轴缩短率(FS)、左心室舒张末内径(LVIDd)、左心室收缩末内径(LVIDs)和左心室心肌质量指数(LVMI)的关系。结果与正常儿童比较,左向右分流CHD病儿血浆BNP和CT-1水平明显升高(t=9.50、3.07,P<0.01);肺动脉高压病儿血浆CT-1水平明显高于正常肺动脉压病儿(t=10.92,P<0.01),且左向右分流CHD病儿血浆CT-1水平与肺动脉压力呈正相关(r=0.512,P<0.05),但与EF、FS、LVIDd、LVIDs和LVMI无相关性(P>0.05);左向右分流CHD病儿血浆BNP水平与EF、FS、LVIDd、LVIDs、LVMI和肺动脉压力均无相关性(P>0.05)。结论血浆BNP和CT-1水平能较好地反映左向右分流型CHD病儿的心功能状态,血浆CT-1水平随肺动脉压力升高而升高。 Objective To investigate the changes and clinical significance of plasma levels of cardiotrophin-1(CT-1) and brain natriuretic peptide(BNP) in children with left-to-right shunt congenital heart disease(CHD). Methods The plasma concentrations of BNP and CT-1 of 25 sick children and 10 healthy ones were measured by using enzyme immunoassay.The relationship between CT-1 or BNP and pulmonary artery pressure(PAP),ejection fraction,fractional shortening,left ventricular internal diameter at end-diastole(LVIDd),left ventricular internal diameter at end-systole(LVIDs),and left ventricular mass index(LVMI) were studied. Results Compared to normal children,the plasma CT-1 and BNP were significantly elevated in the sick children(t=9.50,3.07;P0.01);the plasma CT-1 in those with pulmonary hypertension was higher than that with normal PAP(t=10.92,P0.01).The plasma CT-1 in the sick children was positively correlated with PAP(r=0.512,P0.05),but no correlation with ejection fraction,fractional shortening,LVIDd,LVIDs,LVNI and PAP was found(P0.05). Conclusion The plasma levels of CT-1 and BNP can better reflect cardiac status in children with left-to-right shunt CHD,and the CT-1 levels increase along with the rising of PAP.
出处 《青岛大学医学院学报》 CAS 2010年第4期319-321,325,共4页 Acta Academiae Medicinae Qingdao Universitatis
关键词 心脏缺损 先天性 脑钠肽 心脏营养素-1 heart defects congenital brain natriuretic peptide cardiotrophin-1
  • 相关文献

参考文献15

  • 1PENNICA D,KING K,SHAW K,et al.Expression clone of cardiotrophin-1,a cytokine that induces cardiac myocyte hypertrophy[J].Proc Natl Acad Sci USA,1995,92(8):1142-1146.
  • 2CRAIG R,WAGNER M,MCCARDLE T,et al.The cytoprotective effects of the glycoprotein 130 receptor-coupled cytokine,cardiotrophin-1,require activation of NF-kappa B[J].J Biol Chem,2001,276(40):37621-37629.
  • 3SUDOH T,KANGAWA K,MINAMINO N,et al.A natriuretic peptide in porcine brain[J].Nature,1988,322(1):78-81.
  • 4CASALE P N,DEVEREUX R B,MILNER M,et al.Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men[J].Ann Intern Med,1986,105(2):173-178.
  • 5PENNICA D,SWANSON T A,SHAW K J,et al.Human cardiotrophin-1:protein and gene structure biological and binding activities,and chromosomal localization[J].Cytokine,1996,8(3):183-189.
  • 6马学晓,张高孟,于腾波,冯勇,顾玉东.CT-1对神经再支配骨骼肌功能恢复的促进作用[J].青岛大学医学院学报,2008,44(6):505-507. 被引量:5
  • 7JIANG Z S,JEYARAMAN M,WEN G B,et al.High-but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo:possible involvement of cardiotrophin-1[J].J Mol Cell Cardiol,2007,42(1):222-233.
  • 8FISCHER P,HILFIKER-KLEINER D.Survival pathways in hypertrophy and heart failure:the gp130-STAT3 axis[J].Basic Res Cardiol,2007,102(4):279-297.
  • 9JOUGASAKI M,TACHIBANA I,LUCHNER A,et al.Augmented cardiac cardiotrophin-1 in experimental congestive heart failure[J].Circulation,2000,101(1):14-17.
  • 10POTTER D D,ARAOZ P A.Cardiotropin-1 and myocardial strain change heterogeneously in cardiomyopathy[J].J Surg Res,2007,141(2):277-283.

二级参考文献19

  • 1张伟令,杜忠东.脑钠肽及其在小儿心血管疾病中的临床应用[J].国外医学(儿科学分册),2004,31(6):291-294. 被引量:3
  • 2陈晓亮,郭立明.IL-10对大鼠脊髓损伤后内皮细胞ICAM-1表达作用[J].青岛大学医学院学报,2005,41(3):192-194. 被引量:6
  • 3常红,韩秀珍,王文棣.急性心力衰竭患儿血浆脑钠素及心钠素水平的变化[J].实用儿科临床杂志,2005,20(10):996-998. 被引量:4
  • 4马学晓,张高孟,冯勇,顾玉东,顾建新.心脏营养素-1对失神经骨骼肌的营养和保护作用[J].中华手外科杂志,2006,22(2):112-115. 被引量:9
  • 5PENNICA D, SHAW K J, SWANSON T A, et al. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex [J]. J Biol Chem, 1995,270(18):10915-10922.
  • 6BORDET T, SCHMALBRUCH H, PETTMANN B, et al. Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy [J]. J Clin Invest, 1999,104(8) : 1077-1085.
  • 7LESBORDES J C, CIFUENTES-DIAZ C, MIROGLIO A, et al. Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy[J]. Hum Mol Genet,2003,12 (11),1233-1239.
  • 8Mir TS, Marohn S, Laer S, et al .Plasma concentrations of N terminal probrain natriurtic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure[J].Pediat tics, 2002,110 (6) : 76.
  • 9Laer S,Mir TS,Behn F, et al. Carvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parameters[J]. Am Heart J ,2002,143(5) :916-922.
  • 10Bettencourt P. NT-proBNP and BNP: Biomarkers for heart failure management[J]. EurJ Heart Fail ,2004,6(3) :359 - 363.

共引文献16

同被引文献18

  • 1刘凤云,陈秋红.低氧对高原鼠兔和大鼠血液NO与ET_(-1)的影响(英文)[J].兽类学报,2006,26(1):94-97. 被引量:4
  • 2HYSTAD M E, KLINGE R, SPURKLAND A, et al. Con trasting cardiac regional responses o A-type and B-type natri- uretic peptide to experimental chronic heart failure[J]. Scand J Clin Lab Invest, 2000,60(4)299-309.
  • 3NEUHOLD S, HUELSMANN M, STRUNK G, et al. Com- parison of copeptin, B-type natriuretic peptide, and amlno-ter- minal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the di- sease[J]. J Am Coll Cardiol, 2008,52(4):266-272.
  • 4LAER S, MIR T S, BEHN F, et al. Carvedilol therapy in pe- diatric patients with congestive heart failure., a study investiga- ting clinical and pharmacokinetic parameters[J]. Am Heart J, 2002,143 (5) : 916-922.
  • 5PREIBISZ J J, SEALEY J E, LARAGH J H, et al. Plasma and platelet vasopressin in essential hypertension and congestive heart failure[J]. Hypertension, 1983,5(2 Pt 2) I129-I138.
  • 6KHAN S Q, DHILLON O S, O'BRIEN R J, et al. C-termi- nal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial In- farction Peptide (LAMP) study [ J]. Circulation, 2007, 115 (16) ..2103-2110.
  • 7STOISER B, MORTL D, H LSMANN M, et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure[J]. Eur J Clin Invest, 2006,36 (11) : 771-778.
  • 8MAISEL A S, KRISHNASWAMY P, NOWAK R M, et al. Rapid measurement of B-type natriuretie peptide in the emer- gency diagnosis of heart failure[J]. N Engl J Med, 2002,347 (3) :161-167.
  • 9赵建美,徐美玉.心力衰竭患儿血浆脑利钠肽、内皮素-1与左室舒张末期容量指数、左室射血分数的关系[J].实用儿科临床杂志,2009,24(1):41-43. 被引量:11
  • 10赵桂香,唐庆.慢性心力衰竭患者B型利钠肽和C反应蛋白检测的意义[J].新疆医科大学学报,2009,32(11):1545-1546. 被引量:7

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部